Similar articles

• Preface.

  Prudhomme M. Prudhomme M. Anticancer Agents Med Chem. 2017;17(1):3. Anticancer Agents Med Chem. 2017. PMID: 28143384 No abstract available.
• Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy.

  Abid M, Shamsi F, Azam A. Abid M, et al. Mini Rev Med Chem. 2016;16(10):772-86. doi: 10.2174/1389557515666151001142012. Mini Rev Med Chem. 2016. PMID: 26423699 Review.
• Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.

  Lazarević T, Rilak A, Bugarčić ŽD. Lazarević T, et al. Eur J Med Chem. 2017 Dec 15;142:8-31. doi: 10.1016/j.ejmech.2017.04.007. Epub 2017 Apr 18. Eur J Med Chem. 2017. PMID: 28442170 Review.
• Development of Arene Ruthenium Antitumor Complexes.

  Su W, Tang Z, Li P. Su W, et al. Mini Rev Med Chem. 2016;16(10):787-95. doi: 10.2174/138955751610160503003937. Mini Rev Med Chem. 2016. PMID: 27161008 Review.
• Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands.

  Biersack B. Biersack B. Mini Rev Med Chem. 2016;16(10):804-14. doi: 10.2174/138955751610160503004623. Mini Rev Med Chem. 2016. PMID: 27161009 Review.